Monitoring adherence to vulvar lichen sclerosus treatment - a prospective study
Conclusion: Poor adherence to both twice daily application and prescribed medication quantity occurred frequently. Factors related to self-reported non-adherence included perceived greater efficacy, inconvenience, and time-constraints. Patient adherence to recommended treatment and clinical outcomes are areas for improvement in patients with vulvar lichen sclerosus.PMID:38240095 | DOI:10.1080/09546634.2023.2285725 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 19, 2024 Category: Dermatology Authors: Mallory L Zaino Jessica N Pixley Vani Mangalam Subramanian Deepak Sirdeshmukh Steven R Feldman Rita O Pichardo Source Type: research

Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib
J Dermatolog Treat. 2024 Dec;35(1):2304630. doi: 10.1080/09546634.2024.2304630. Epub 2024 Jan 19.NO ABSTRACTPMID:38240097 | DOI:10.1080/09546634.2024.2304630 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 19, 2024 Category: Dermatology Authors: Francisco Javier De la Torre-Gomar Juan Pablo Velasco-Amador Álvaro Prados-Carmona Ricardo Ruiz-Villaverde Source Type: research

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
J Dermatolog Treat. 2024 Dec;35(1):2304027. doi: 10.1080/09546634.2024.2304027. Epub 2024 Jan 19.ABSTRACTBackground: Injection site reaction (ISR) is a local phenomenon defined as a constellation of symptoms, including swelling, erythema, pruritus, and pain around the site of injection.Objective: ISR is reported as a frequent adverse event after subcutaneous injection (SCI) of several biologics.Methods: We performed an observational real-life study to compare dupilumab and tralokinumab as regards ISR, analysing frequency, duration and intensity of symptoms related to SCI. From January 2023 to June 2023, we enrolled adult p...
Source: Journal of Dermatological Treatment - January 19, 2024 Category: Dermatology Authors: Fabrizio Martora Cataldo Patruno Silvia D'Ascenzo Maddalena Napolitano Source Type: research

Correction
J Dermatolog Treat. 2024 Dec;35(1):2302710. doi: 10.1080/09546634.2024.2302710. Epub 2024 Jan 19.NO ABSTRACTPMID:38240290 | DOI:10.1080/09546634.2024.2302710 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 19, 2024 Category: Dermatology Source Type: research

Is apremilast a treatment for SAPHO syndrome?
J Dermatolog Treat. 2024 Dec;35(1):2300743. doi: 10.1080/09546634.2023.2300743. Epub 2024 Jan 17.NO ABSTRACTPMID:38230420 | DOI:10.1080/09546634.2023.2300743 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 17, 2024 Category: Dermatology Authors: Ju Zhang Yixuan Li Jing Wang Huan Jiang Jiaping Qi Chen Li Zhenhua Ying Source Type: research

Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis
CONCLUSION: EL combined with antioxidants was the preferred regimen for vitiligo, whereas EL alone was the regimen with the highest rate of treatment failure in vitiligo.PMID:38230424 | DOI:10.1080/09546634.2024.2302064 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 17, 2024 Category: Dermatology Authors: ChanXiu Li Yue Hu ZengYi Mu Lei Shi Xiao Sun XinYue Wang YaPing Wang XinHong Li Source Type: research

Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment
This study aimed to quantify the conditional relative importance (CRI) of attributes of topical treatments for MM AD among adult and adolescent patients and caregivers of children with MM AD.Materials and methods: A discrete-choice experiment (DCE) survey was administered to US adults and adolescents with MM AD and caregivers of children with MM AD. Each choice task comprised 2 hypothetical topical treatments characterized by efficacy, adverse events, vehicle, and application frequency. Data were analyzed using a random-parameters logit model to calculate the CRI of each attribute.Results and conclusions: 300 adults, 331 a...
Source: Journal of Dermatological Treatment - January 15, 2024 Category: Dermatology Authors: Steven R Feldman Jacob P Thyssen Marco Boeri Robert Gerber Maureen P Neary Amy Cha Brett Hauber Joseph C Cappelleri Jason Xenakis Colton Leach Joshua Zeichner Source Type: research

Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis
J Dermatolog Treat. 2024 Dec;35(1):2300354. doi: 10.1080/09546634.2023.2300354. Epub 2024 Jan 11.NO ABSTRACTPMID:38213229 | DOI:10.1080/09546634.2023.2300354 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 12, 2024 Category: Dermatology Authors: Lawrence F Eichenfield Jonathan I Silverberg Adelaide A Hebert Mark Boguniewicz Source Type: research

The differences in the count of B lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in healthy subjects in pollen season and out of pollen season
J Dermatolog Treat. 2024 Dec;35(1):2290360. doi: 10.1080/09546634.2023.2290360. Epub 2024 Jan 11.NO ABSTRACTPMID:38213263 | DOI:10.1080/09546634.2023.2290360 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 12, 2024 Category: Dermatology Authors: Jarmila Čelakovská Eva Čermáková Ctirad Andr ýs Petra Boudkova Jan Krejsek Source Type: research

The cutaneous effects of androgens and androgen-mediated sebum production and their pathophysiologic and therapeutic importance in acne vulgaris
Conclusions: We have summarized the current evidence in support of the therapeutic benefits of targeted hormonal treatment to decrease androgen-stimulated sebum production for the effective and safe treatment of AV in both male and female patients.PMID:38192024 | DOI:10.1080/09546634.2023.2298878 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 9, 2024 Category: Dermatology Authors: James Q Del Rosso Leon Kircik Source Type: research

A novel predictive method for risk stratification in acne patients receiving isotretinoin: an analysis of laboratory abnormalities and changes in inflammatory parameters
CONCLUSIONS: We found that a baseline cholesterol level of 163.9 mg/dl and a baseline triglycerides level of 85.5 mg/dL are highly specific and sensitive in detecting grade 1 abnormalities at the one-month follow-up. This novel prediction approach serves as an effective risk stratification method for isotretinoin acne patients.PMID:38186323 | DOI:10.1080/09546634.2023.2301435 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 8, 2024 Category: Dermatology Authors: Rand Murshidi Salsabiela Bani Hamad Assem Al Refaei Nour Shewaikani Moayad Shaf'ei Sara N Alshoubaki Tala A Haddad Tawfiq Khasawneh Taima Fkheideh Mahmoud Abdallat Source Type: research

Evaluation of innate lymphoid cells and their subsets in atopic dermatitis patients with and without dupilumab therapy
J Dermatolog Treat. 2024 Dec;35(1):2299721. doi: 10.1080/09546634.2023.2299721. Epub 2024 Jan 4.NO ABSTRACTPMID:38174384 | DOI:10.1080/09546634.2023.2299721 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - January 4, 2024 Category: Dermatology Authors: Jarmila Čelakovská Eva Čermáková Petra Boudkova Jan Krejsek Source Type: research